Clinical Trial Update: A Clinical Trial Comparing Cangrelor to Clopidogrel Standard Therapy in Subjects Who Require Percutaneous Coronary Intervention (PCI) (CHAMPION PHOENIX) [Phase 3]

View source ↗

Summary

Phase 3 CHAMPION PHOENIX trial comparing cangrelor with clopidogrel in patients undergoing percutaneous coronary intervention completed with posted results in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Coronary Syndrome

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)
• Cangrelor (cangrelor)

Snippet

Sponsor: The Medicines Company | Conditions: Atherosclerosis, Percutaneous Coronary Intervention | Phase 3 | Status: COMPLETED | Results posted: 2013-06-18